Clinical Trial

Synergistic Gut-brain Axis Modulation Via Vagal Stimulation and Support Therapy in Functional Dyspepsia

Study acronym: CONVERGE
Recruiting
View on ClinicalTrials.gov →
Summary
The study aims at evaluating physiological and patient-reported outcomes for a dual intervention approach including a stimulation device and support therapy in patients with functional dyspepsia.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-04-08; most recent amendment 2026-07-14.
Status change: Not Yet Recruiting → Recruiting 2025-10-29
Trial Details
NCT Number NCT06360900
Lead Sponsor Spaulding Rehabilitation Hospital
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Functional Dyspepsia
Enrollment 80 participants
Start Date 2025-10-29
Primary Completion 2029-03 (estimated)
Study Completion 2029-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-15